VentureBeat December 27, 2020
Kyle Wiggers

The first shipments of Pfizer’s and Moderna’s COVID-19 vaccines arrived at health systems across the U.S. this month, a significant milestone in the fight against a pandemic that has infected and killed millions of people. But vaccine distribution and administration is a major logistical challenge, not least because both vaccines require cold storage. Nevertheless, Operation Warp Speed, the U.S. public-private COVID-19 treatment partnership, optimistically aims to vaccinate tens of millions of people by year’s end.

Some stakeholders are turning to AI for help, particularly robotic process automation, or RPA — software that emulates the actions of humans interacting with systems. RPA could bolster efficiency in hospitals and supply chains overwhelmed by the challenges of COVID-19 vaccine management.

For example, San...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Robotics/RPA, Technology
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Here’s The Second Humanoid Robot To Get A Paying Job
CES 2025: 20 Tech Experts Predict Highlights And Trends
Study explores factors influencing acceptance of home-care robots
FHC #157: NVIDIA expects AI, robots to cure healthcare’s biggest problems

Share This Article